Biomarkers for ventilator-associated pneumonia: Review of the literature

Heart and Lung: Journal of Acute and Critical Care

Volumn 40, Issue 4, 2011, Pages 293-298

  Palazzo, Steven J ^a,b   Simpson, Terri ^b   Schnapp, Lynn ^a,b  

^a Center for Lung Biology   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Biomarker; Bronchoscopy; C reactive protein; Directed BAL; Non directed BAL; Procalcitonin; Sensitivity; Soluble triggering receptor expressed on myeloid cells type 1; Specificity; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ALGORITHM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CRITICALLY ILL PATIENT; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DRUG USE; FALSE NEGATIVE RESULT; HORMONE BLOOD LEVEL; HUMAN; INTENSIVE CARE; LUNG LAVAGE; MEDLINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CRITICAL CARE; HEALTH STATUS INDICATORS; HUMANS; MEMBRANE GLYCOPROTEINS; PNEUMONIA, VENTILATOR-ASSOCIATED; PROTEIN PRECURSORS; RECEPTORS, IMMUNOLOGIC; SENSITIVITY AND SPECIFICITY;

EID: 79959858140     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2010.11.003     Document Type: Review

References (42)

1. Chastre J., Fagon J. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
2. Rello J., Ollendorf D., Oster G., Vera-Llonch M., Bellm L., Redman R., et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002, 122:2115-2121.
3. Luyt C., Combes A., Reynaud C., Hekimian G., Nieszkowska A., Tunnerlier M., et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008, 34:1434-1440.
4. Heyland D., Cook D., Griffith L., Keenan S., Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999, 159(4 Pt 1):1249-1256.
5. Papazian L., Bregeon F., Thirion X., Gregoire R., Saux P., Denis J.P., et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996, 154:91-97.
6. Safdar N., Dezfulian C., Collard H., Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005, 33:2184-2193.
7. Tablan O., Anderson L., Besser R., Bridges C., Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004, 53(RR-3):1-36.
8. Fagon J., Chastre J., Wolff M., Gervais C., Paer-Aubas S., Stephan F., et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000, 132:621-630.
9. Pugin J., Auckenthaler R., Mili N., Janssens J., Lew P., Suter P. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991, 143(5 Pt 1):1121-1129.
10. Schurink C., Van Nieuwenhoven C., Jacobs J., Rozenberg-Arska M., Joore H.C., et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med 2004, 30:217-224.
11. Huh J., Lim C., Koh Y., Oh Y.M., Shim T.S., Lee S.D., et al. Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates. Crit Care 2008, 12:R6.
12. Fartoukh M., Maitre B., Honoré S., Cerf C., Zahar J., Brun-Buisson C. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med 2003, 168:173-179.
13. Croce M., Swanson J., Magnotti L., Claridge J.A., Weinberg J.A., Wood G.C., et al. The futility of the clinical pulmonary infection score in trauma patients. J Trauma 2006, 60:523-528.
14. Luyt C., Chastre J., Fagon J. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med 2004, 30:844-852.
15. Inglis T., Millar M., Jones J., Robinson D. Tracheal tube biofilm as a source of bacterial colonization of the lung. J Clin Microbiol 1989, 27:2014-2018.
16. Adair C., Gorman S., Feron B., Byers L.M., JOnes D.S., Goldsmoith C.E., et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 1999, 25:1072-1076.
17. Mayhall C. Ventilator-associated pneumonia or not? Contemporary diagnosis. Emerg Infect Dis 7:200-4.
18. Póvoa P. Serum markers in community-acquired pneumonia and ventilator-associated pneumonia. Curr Opin Infect Dis 2008, 21:157-162.
19. Bouadma L., Luyt C., Tubach F., Cracco C., Alvarez A., Schwebel C., et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375:463-474.
20. Bouchon A., Facchetti F., Weigand M., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410:1103-1107.
21. Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000, 164:4991-4995.
22. Mahdy A., Lowes D., Galley H., Bruce J., Webster N. Production of soluble triggering receptor expressed on myeloid cells by lipopolysaccharide-stimulated human neutrophils involves de novo protein synthesis. Clin Vaccine Immunol 2006, 13:492-495.
23. Gingras M., Lapillonne H., Margolin J. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol 2002, 38:817-824.
24. Gibot S., Kolopp-Sarda M., Béné M., Bollaert P.E., Lozniewski A., Mory F., et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 2004, 200:1419-1426.
25. Anand N., Zuick S., Klesney-Tait J., Kollef M. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009, 135:641-647.
26. Oudhuis G., Beuving J., Bergmans D., Stobberingh E.E., ten Velde G., Linssen C.F., et al. Soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med 2009, 35:1265-1270.
27. Horonenko G., Hoyt J., Robbins R., Singarajah C.U., Umar A., Pattengill J., et al. Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 2007, 132:58-63.
28. Bopp C., Hofer S., Bouchon A., Zimmermann J., Martin E., Weigand M. Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation. Eur J Anaesthesiol 2009, 26:504-507.
29. Ferat-Osorio E., Wong-Baeza I., Esquivel-Callejas N., Figueroa-Figueroa S., Duarte-Rojo A., Guzmán-Valdivia-Gómez G., et al. Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Crit Care 2009, 13:R69.
30. Ramirez P., Garcia M., Ferrer M., Aznar J., Valencia M., Sahuquillo J.M., et al. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J 2008, 31:356-362.
31. Maruna P., Nedelníková K., Gürlich R. Physiology and genetics of procalcitonin. Physiol Res 2000, 49(Suppl 1):S57-S61.
32. Duflo F., Debon R., Monneret G., Bienvenu J., Chassard D., Allaouchiche B. Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 2002, 96:74-79.
33. Gibot S., Cravoisy A. Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. Clin Med Res 2004, 2:181-187.
34. Determann R., Millo J., Gibot S., Korevaar J.C., Vroom M.B., van der Poll J., et al. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 2005, 31:1495-1500.
35. Oppert M., Reinicke A., Müller C., Barckow D., Frei U., Eckardt K. Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation 2002, 53:167-170.
36. Tang H., Huang T., Jing J., Shen H., Cui W. Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 2009, 37:497-507.
37. Schuetz P., Christ-Crain M., Thomann R., Falconnier C., Wolbers M., Widmer I., et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009, 302:1059-1066.
38. Kristoffersen K., Søgaard O., Wejse C., Black F.T., Greve T., Tarp B., et al. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission-a randomized trial. Clin Microbiol Infect 2009, 15:481-487.
39. Póvoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med 2002, 28:235-243.
40. Pepys M., Hirschfield G. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
41. Póvoa P., Coelho L., Almeida E., Fernandez A., Mealhar R., Moreira D., et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005, 11:101-108.
42. Póvoa P., Coelho L., Almeida E., Fernandez A., Mealhar R., Moreira D., et al. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005, 25:804-812.